Examination of Stat3 levels in certain NSCLC lines demonstrated that Src is a major Stat3 activator [46], while in another report [47] Src inhibition in different NSCLC lines was found to actually increase Stat3-ptyr705. This evidence concerns the gene SRC and non-small cell lung carcinoma.